Generex Biotechnology Corp. (fka GNBTQ)

[grobtekrebssvindl]

Memories:the Antigen spin out swindle

Generex Appoints Jos van der Woert CEO for Post-Spinout Antigen Express
June 15, 2011

"We are pleased to have secured the services of an executive of Mr. van der Woert's experience and expertise," commented Mark Fletcher, Generex President & Chief Executive Officer. "Upon the rebirth of Antigen Express as a stand-alone public company, Mr. van der Woert, together with Dr. Eric von Hofe as President, will provide the strong and capable leadership necessary to shepherd the company and its proprietary immunotherapeutic vaccine technologies into the future."

Mr. van der Woert stated: "I am excited to lead the Antigen Express spinoff with its proprietary AE37 cancer vaccine platform technology which holds such tremendous promise as an immunotherapy that may become an integral part of the future treatment paradigm."

On March 30, 2011, Generex announced its intention to spinout Antigen Express, Inc. as a stand-alone public company and to provide Antigen Express stock dividends to the Generex stockholders following a reverse split of the Generex stock. That reverse stock split was approved by the Generex stockholders on June 8, 2011. Generex will provide further details of the Antigen Express spinout in the coming weeks."

Well Jos van der Woert does not even mention Generex or Antigen in his profile,resume.I guess he has a very good reason not to include a well known fraud company in it

http://boston.citybizlist.com/article/generex-appoints-jos-van-der-woert-ceo-post-spinout-antigen-express-0